A clinical-stage biotech developing engineered #cytokines, called #Superkines: IL2 asset (MDNA11), Phase 3 ready rGBM asset (MDNA55) - TSX: $MDNA OTCQX: MDNAF

ID: 1024741689158762498

linkhttp://www.medicenna.com calendar_today01-08-2018 19:40:32